PARSIPPANY, NJ--(Marketwired - May 9, 2013) - The Medicines Company (NASDAQ: MDCO) today announced that the U.S. Food and Drug Administration (FDA) has expanded the indication for RECOTHROM®, Thrombin ...

Discover comprehensive details about Thrombin Topical Bovine Origin, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The ...

February 5, 2010 — Results from 8 clinical trials show that recombinant human thrombin (rThrombin; Recothrom, ZymoGenetics, Inc) is well tolerated in several surgical settings for topical hemostasis ...

Please provide your email address to receive an email when new articles are posted on . Based upon increased concerns about the infectious and noninfectious risks of blood transfusions, physicians are ...

Review the side-effects of Thrombin Topical Bovine Origin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.

The FDA Thursday approved ZymoGenetics Inc.'s Recothrom Thrombin, the first and only recombinant, plasma-free thrombin for use as a topical hemostat. News of the approval sent shares of ZymoGenetics ...

First and Only Bovine-Free Stand-Alone Topical Thrombin Approved by FDA NEW YORK -- OMRIX Biopharmaceuticals, a commercial-stage biopharmaceutical company that develops and markets biosurgical and ...

Additional Recothrom vial size approved The FDA has approved ZymoGenetics' Recothrom (recombinant topical thrombin) for use as an aid to hemostasis when oozing blood and minor bleeding from ...

Does re-exposure to recombinant human thrombin result in sensitization? The authors investigated this problem in 31 adult patients who had previously been exposed to recombinant human thrombin during ...

Bayer will retain the Canadian license, while ZymoGenetics will look for partners in ex-U.S. territories. ZymoGenetics is regaining global promotion rights, except Canada, for Recothrom Thrombin, ...

The labeling for Thrombin-JMI (topical bovine thrombin, from King Pharmaceuticals) has been updated to recognize the enhanced purification process that reduces bovine Factor V light chain content to ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global medical products company, is committed to advancing surgical innovation and today announced it has completed its ...